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For most bacterial pathogens, adherence of the bacterium to the surface
of the host cell tissue is a necessary first step for colonization and infection.
Agents that inhibit adherence, therefore, could be useful for preventing infections.
The goal of this research was to assess the anti-adherent activity of several foodgrade prebiotic carbohydrates, plant extracts, and other naturally-derived
molecules against enteric pathogens. First, the antiadherent effect of
galactooligosaccharides (GOS), polydextrose (PDX), and a GOS-PDX blend was
tested against two strains of Cronobacter “Enterobacter” sakazakii. When
measured microscopically or by cultural methods, significant reductions in
adherence (56% and 71%, respectively) of C. sakazakii were observed in the
presence of GOS (16 mg/ml). Adherence inhibition also occurred (48%) when
the GOS-PDX blend (8 mg/ml each) was tested, although PDX by itself had less
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effect. Subsequently, the ability of several prebiotic agents, including
chitooligosaccharides (COS) and mannan oligosaccharides derived from yeast
cell walls (MOSy) and konjac root (MOSk), to inhibit adherence of
enteropathogenic Escherichia coli (EPEC), enterohemorragic Escherichia coli
(EHEC) and Salmonella typhimurium to a human HEp-2 cell line was tested. In
addition, a high molecular weight component of cranberry (CHMW) was also
assessed for anti-adherence. Different fractions of COS significantly reduced
adherence of EPEC at a concentration of 16 mg/ml. Although MOSy inhibited
EPEC, EHEC, and S. typhumiurim, adherence inhibition was not observed for
MOSk. Adherence inhibition of EPEC, EHEC, and S. typhumiurim by CHMW
was observed. Finally, the ability of two different types of lactoferrin to inhibit
adherence of Cronobacter sakazakii to a HEp-2 human cell line was assessed.
Results showed that the adherence of C. sakazakii was significantly reduced at a
minimum concentration of 10 mg/ml. However, at higher concentrations (up to
50 mg/ml), further reductions in adherence were not observed. These results
show that different prebiotics, plant extracts, and other molecules may be added
to foods as a prophylactic treatment to prevent or mitigate infections by enteric
pathogens.
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Preface
This thesis is comprised of five chapters. Chapter 1 provides a review of
the current literature on the anti-adherent effect of different prebiotic
oligosaccharides and plant extracts. Chapter 2 describes our published (Quintero
et al. 2011 Current Microbiology) results focusing on the antiadhesive effect of
galactooligosaccharides

(GOS)

and

polydextrose

(PDX),

alone

and

in

combination, against Cronobacter sakazakii. Chapter 3 describes the results
obtained

when

testing

the

antiadherent

effect

of

different

prebiotic

oligosaccharides and plant extracts against EPEC, EHEC, and Salmonella
typhimurium. Chapter 4 describes results on the antiadherent effect of lactoferrin
against Cronobacter sakazakii at different doses. Finally, Chapter 5 provides a
conclusion section that summarizes the major research findings presented within
this thesis.

vi

Table of Contents
Page
Abstract……………….…………………………………………………...………i
Acknowledgements………………………………….………………………….iii
Preface……………………………………………………………………….......v
Table of Contents…………………………….…………………………………vi
List of Tables…………………………….………………………….……………x
List of Figures…………………………….………….……………….…………xi

Chapter
1. Prebiotic Oligosaccharides, Plant Extracts, and Naturally Derived
Molecules: A review on Their Beneficial Effects and Anti-adherent
Activity Against Pathogens…………………..…………………………1
Introduction………………………………………………………………2
Prebiotics, oligosaccharides, and human health…………………….3
I.

Galactooligosaccharides (GOS)……………………………….5

II.

Inulin………………………………………………………………6

III.

Fructooligosaccharides (FOS)…………………………………6

vii

IV.

Xylooligosaccharides (XOS)…………………………………...7

V.

Polydextrose (PDX)……………………………………..………7

VI.

Mannan oligosaccharides (MOS)……………………………...8

VII.

Pectic oligosaccharides (POS)………………………………...9

VIII.

Chitooligosaccharides (COS)………………………………….9

The antiadherence model………………………….…………………10
I.

Anti-adherent oligosaccharides from human milk………….12

II.

Galactooligosaccharides as anti-adherent agents…………13

III.

Mannan oligosaccharides as anti-adherent agents………..14

IV.

Pectic oligosaccharides as antiadherent agents………...…14

Other anti-adherent agents………………………………………..….15
I.

Anti-adherent properties of cranberry……………………….15

II.

Anti-adherent properties of lactoferrin……………………….17

Prebiotics

as

therapeutic

agents

against

the

emerging

pathogen……………………………………………………………......19
I.

Cronobacter sakazakii………………………………………...19

Conclusion……………………………………………………………...22
References……………………………………………………………..24
Chapter

viii

2. Adherence Inhibition of Cronobacter sakazakii to intestinal epithelial
cells by prebiotic oligosaccharides………………………..…………54
Abstract…………………………………………………………………56
Introduction……………………………………………………………..57
Materials and Methods………………………………………………..59
Results…………………………………………………………………..62
Discussion………………………………………………………………64
Conclusions…………………………………………………………….66
Acknowledgements……………………………...…………………….67
References…………………………………………………..…………68
Chapter
3. Adherence

Inhibition

of

Intestinal

Pathogens

by

Prebiotic

Oligosaccharides and Plant Extracts………………………………...83
Abstract……………...………………………………………………….84
Introduction……………………………………………………………..84
Materials and Methods………………………………………………..87
Results…………………………………………………..………………92
Discussion………………………………………………………………93
Conclusions……………………………………………………………96
Acknowledgements………………...………………………………….96
References………………………………………………………..……97
Chapter

ix

4. Lactoferrin as an anti-adherent agent: Inhibition of Cronobacter
sakazakii adherence to epithelial cells……………………………..112
Abstract……………..…………………………………………………113
Introduction……………………………………………………………113
Materials and Methods……………………………………………....116
Results………..……………………………………………………….118
Discussion…………………………………………………………….119
Conclusion……………………….……………………………………120
Acknowledgements……………………………..……………………121
References…………………………...……………………………….122
Chapter
5. Conclusion………………………………….…………………………132

x

List of Tables
Page
Chapter 2:
1. Strains and Sources………………….…………………..………..….82
Chapter 3:
1. Primers and PCR programs for the different organisms used in this
study……………….……………………………………………………91
Chapter 4:
1. Primers and qRT-PCR program………………………………….…132

xi

List of Figures
Page
Chapter 1:
1. Bacterial adhesion involving lectin-carbohydrate interactions:
bacterial lectin-host glycoprotein (A1); bacterial lectin-host glycolipid
(A2); host lectin-bacterial LPS (A3); hydrophobin-protein
interactions (B); protein-protein interactions (C). Adapted from Ofek
et al. 2003………………………………………………..……………..11
Chapter 2:
1. Adherence of C. sakazakii 4603 to Hep-2 cells in the presence of
prebiotics (16 mg/ml). In A, adherence was measured by
microscopic counting (n = 10), and in B, adherence was measured
by cultural enumeration (n = 6). Statistically significant effects (p <
0.05) are indicated by the asterisk………………………………..….74
2. Adherence of C. sakazakii 29004 to Hep-2 cells in the presence of
prebiotics (16 mg/ml). In A, adherence was measured by
microscopic counting (n = 10), and in B, adherence was measured
by cultural enumeration (n = 6). Statistically significant effects (p <
0.05) are indicated by the asterisk…………………………………...76
3. Adherence of C. sakazakii 4603 to Hep-2 cells in the absence (A)
and presence of GOS (B), GOS-PDX (C); and PDX (D)…………..78

xii

4. Adherence of C. sakazakii 29004 to Caco-2 cells in the presence of
prebiotics (16 mg/ml). Adherence was measured by microscopic
counting (n = 4) at 1000 x magnification. Significant effects (versus
the control) are indicated by the asterisk (p < 0.05)…………..……80
Chapter 3:
1. Adherence of EPEC, EHEC, and Salmonella typhimurium to HEp-2
cells in the presence of a cranberry HMW component (0, 0.2, 0.4,
0.8, 1, and 2 mg/ml) analyzed by qRT-PCR (n=6) (A, C) and
microscopic counting (n=4) (B, D, F). Statistically significant effects
are indicated by an asterisk…………………………………………102
2. Adherence of EPEC and Salmonella typhimurium to HEp-2 cells in
the presence of a neutralized cranberry concentrate analyzed by
qRT-PCR (n=6). Statistically significant effects are indicated by an
asterisk………………………………….……………………………..104
3. Adherence of EPEC to HEp-2 cells in the presence of COS
analyzed by microscopic enumeration. (n=6) Statistically significant
effects are indicated by an asterisk…………………………..…….106
4. Adherence of EPEC, EHEC, and Salmonella typhimurium to HEp-2
cells in the presence of MOSk analyzed by qRT-PCR (n=6) (A, C,
D) and microscopic counting (n=4) (B). Statistically significant
effects are indicated by an asterisk………………………...………108
5. Adherence of EPEC, EHEC, and Salmonella typhimurium to HEp-2
cells in the presence of MOSy by qRT-PCR (A, C, D) (n=6) and

xiii

microscopic counting (B) (n=4). Statistically significant effects are
indicated by an asterisk………………………………...……………110
Chapter 4:
1. Adherence of Cronobacter sakazakii 4603 to HEp-2 cells in the
presence of Lactoferrin 003 at doses ranging from 0 to 50 mg/ml.
Statistically significant effects are indicated by an asterisk……...128
2. Adherence of Cronobacter sakazakii 4603 to HEp-2 cells in the
presence of Lactoferrin 004 at doses ranging from 0 to 50 mg/ml.
Statistically significant effects are indicated by an asterisk……...130

1

Chapter 1
Prebiotic Oligosaccharides, Plant Extracts, and Naturally Derived
Molecules: A review on Their Beneficial Effects and Anti-adherent Activity
Against Pathogens

2

Introduction
Prebiotics are a group of dietary components that have received
considerable attention due to their ability to modulate the gastrointestinal
microbiota and confer health benefits to the host. Prebiotics were initially defined
in rather narrow terms as “non-digestible food ingredients that provide a
beneficial effect to the host by stimulating the growth of selected members of the
gastrointestinal tract, and thus improve host health”’(Gibson et al. 1995). More
recently, prebiotics were redefined as “selectively fermented ingredient(s) that
allows specific changes, both in the composition and/or activity in the
gastrointestinal microflora, that confers benefits upon host well-being and health
(Roberfroid 2007). However, by either definition, food ingredients have been
considered as prebiotics based exclusively on their ability to cause changes in
the intestinal microbiota.
Among the food components considered as prebiotics, most are
comprised of soluble oligosaccharides and polysaccharides. Some dietary fibers
have also been suggested as having prebiotic characteristics, although not all of
them fulfill the requirements to be classified as prebiotic (Roberfroid 2007). To
avoid claims that are not fully supported, Roberfroid suggested that a food
ingredient can be classified as a prebiotic if: i) it is not hydrolyzed, nor absorbed
in the upper part of the gastrointestinal tract, ii) it is a selective substrate for
beneficial members of the gastrointestinal tract, which will be stimulated to grow
or be metabolically activated, iii) it is able to alter the intestinal microflora in favor
of a healthier composition, and iv) it is able to induce systemic effects that are
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beneficial to host health (Gibson et al. 1995; Roberfroid 1993; Roberfroid 1998).
Non-digestible oligosaccharides such as inulin, galactooligosaccharides (GOS),
and fructooligosaccharides (FOS) are now well established as prebiotics;
however, more research is needed to determine whether xylooligosaccharides,
soybean oligosaccharides, and glucooligosaccharides, should be regarded as
prebiotics (Roberfroid 2007; Gibson et al. 2004; Roberfroid 2000).
Despite the criteria described above, studies have been reported in recent
years that indicate prebiotics may enhance host health not only by shifting the
gut microbiota but by an entirely different biological function. Specifically, several
research groups have shown that prebiotics may directly prevent infections by
inhibiting the ability of pathogenic bacteria to adhere to target tissues in the host
(Shoaf et al. 2006; Gibson et al. 2005; Saulnier et al. 2009). In this chapter, the
bifidogenic health benefits of prebiotics will be briefly reviewed, but particular
attention will be devoted to their antiadherence activities and the proposed model
by which prebiotics can be used to inhibit foodborne infections. Additionally, the
antiadherent activity of novel prebiotic oligosaccharides and plant extracts will be
addressed.
Prebiotics, oligosaccharides, and human health
Among the most well studied prebiotics are inulin, FOS, and GOS. They
are either extracted from natural sources (e.g., inulin from chicory root), produced
via hydrolysis of plant polysaccharides (e.g., FOS from inulin) or synthesized
enzymatically from sugars found in milk or plant material (e.g., FOS and GOS
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from sucrose and lactose, respectively) via glycosyl transferase reactions
(Grizard & Barthomeuf 1999; L'Hocine 2000). Interestingly, human milk and
colostrum from lactating animals also contain high concentrations (> 1%) of
oligosaccharides (Coppa et al. 2008) that have prebiotic activity.
That these two groups of oligosaccharides (i.e., those that are food grade
and those are obtained from human milk) have general structural similarities has
led to the suggestion that they may also share similar biological activities. It is
well known that human milk is already a very rich source of nutrients, including
oligosaccharides that are important for the health of the infant during the first few
months of life (Coppa et al. 2006). This oligosaccharides fraction, which can
reach concentrations as high as 8 to 12 g/L (Kunz et al. 2000), is comprised of
sialic acid, N-acetylglucosamine, L-fucose, D-glucose, and D-galactose.
Galactose residues form three different types of oligosaccharides found in human
milk: 3’-galactosyl-lactose, 4’galactosyl-lactose, and 6’-galactosyl-lactose
(Boehm et al. 2005; Torres et al. 2010). The absence of fucose and amine
groups in commercial GOS products distinguishes these OS from human milk
OS and has led some researchers to argue that these structural differences “do
not support a direct parallel functionality and thus, need to be further
investigated” (Kunz et al. 2009).
The effect of prebiotics on the human gastrointestinal microbiota has been
the subject of extensive study. This interest has been due largely to the
bifidogenic properties of prebiotics and the many observations showing that high
levels of bifidobacteria in the intestinal tract are correlated with health benefits in
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humans. Specifically, these organisms have been associated with increased
resistance to infection and diarrhea (Saavedra 1994; Tojo et al. 1987; Yamazaki
et al. 1985), stimulation of the immune system (Kirjavainen et al. 2002; Sekine et
al. 1985), and protection against cancer (Reddy et al. 1993) as well as increased
production of short chain fatty acids. Convincing evidence has also emerged
showing that bifidobacteria are the main species colonizing the infant
gastrointestinal tract and that a bifidobacteria-rich microbiota protects the infant
against pathogenic bacteria (Stark et al. 1982; Moro et al. 2002; Penders et al.
2006; Weizman et al. 2005). However, the proportion of bifidobacteria decreases
with age, thus efforts to restore or increase this population are warranted.
Galactooligosaccharides (GOS)
Commercial GOS is enzymatically synthesized from lactose using
glycoside hydrolases (Roode et al. 2003) that catalyze transgalactosylation
reactions (Crittenden et al. 1996). Resulting products have different linkages
depending on the enzyme source. Commercially available GOS commonly
includes β-1,3, β-1,4, or β-1,6 linkages (Torres et al. 2010). Like other prebiotics,
GOS selectively stimulates the growth of bifidobacteria and lactobacilli in the host
gastrointestinal tract (Teuri et al. 1998; Moro et al. 2002; Bouhnik et al. 2004;
Depeint et al. 2008). Doses necessary to elicit a bifidogenic response vary from
2.5 to 10 g per day (Moro et al. 2002; Sako 1999; Depeint et al. 2008; Silk et al.
2009). However, recent studies also suggest that the bifidogenic effect of GOS
is not only dose dependant, but relies on undefined host factors (Davis et al.
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2010). GOS is marketed throughout the world and is self-affirmed as GRAS in
the U.S.
Inulin
Inulin, a naturally-occurring plant polysaccharide, is one of the most widely
consumed prebiotics. It is a β-2,1 fructan with a degree of polymerization (DP)
ranging from 2 to 60 (Costabile et al. 2010). Inulin is characterized for having a
bifidogenic effect when consumed in a regular basis. Human trials have been
reported that show significant increases in bifidobacteria after regular
consumption of inulin at doses ranging from 5 to 40 g/day (Kolida et al. 2007;
Kruse et al. 1999; Gibson 1995; Kleessen et al. 1997; Kleessen et al. 2007; de
Preter et al. 2008). Inulin is legally classified as a food ingredient in all the
countries in which it is used .
Fructooligosaccharides (FOS)
Two forms of fructooligosaccharides (FOS) are produced commercially.
One form is derived from hydrolysis of inulin and consists mainly of β-2,1 fructose
oligosaccharides, along with fructooligosaccharides chains containing glucose at
the terminal end. The other commercial form of FOS is obtained enzymatically
from sucrose via a transfructosylation reaction. This FOS contains a mixture of
oligosaccharides, each consisting of glucose linked to two, three, or four fructose
units (Molis et al. 1996). Human trials where FOS was consumed on a regular
basis showed an increase in bifidobacterial levels; daily doses ranged from 2.5 to
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20 g/day. (Bouhnik et al. 1999; Tuohy et al. 2001; Buddington et al. 1996; Menne
et al. 2000; Bouhnik et al. 2007; Guigoz 2002; Williams et al. 1994)
Xylooligosaccharides (XOS)
Xylooligosaccharides are sugar oligomers made up of xylose units. They
are found naturally in bamboo, fruits, vegetables, milk, and honey and are
industrially produced form lignocellulosic materials (LCM) which come from a
variety of feedstocks (Vázquez 2000). There are three different approaches
used to produce XOS from xylan-rich feedstocks: a) enzyme treatments of
native, xylan containing LCM, b) chemical fractionation of LCM to isolate or
solubilize xylan, with further enzymatic hydrolysis of the polymer to XOS, and c)
hydrolytic degradation of xylan to XOS by steam, water or dilute solutions of
mineral acids (Vázquez 2000). As for other prebiotics, XOS have been reported
to modulate the gut microbiota, especially stimulating the growth of Bifidobacteria
(Rycroft et al. 2001; Zampa et al. 2004). Although data on human studies is
limited, studies have shown increases of 10 to 30% in bifidobacteria following
consumption of XOS.
Polydextrose (PDX)
Polydextrose (PDX) is a polysaccharide synthesized by random
polymerization of glucose and sorbitol, using an appropriate acid catalyst at high
temperature and partial vacuum conditions. It is widely used as a low calorie
bulking agent in prepared foods (Jie et al. 2000). Unlike other prebiotics, PDX is
only partially fermented by intestinal microorganisms, due to the nature of the
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glycosidic bonds, and high amounts are excreted in feces (Achour et al. 1994;
Figdor et al. 1981). The partial fermentation in the large intestine leads to
reduced transit time, softer stools, and lower fecal pH (Achour et al. 1994). The
prebiotic activity of PDX remains unclear, although there are reports that it
promotes proliferation of favorable microflora, including bifidobacteria, and
decreases bowel pH (Jie et al. 2000).
Mannan oligosaccharides (MOS)
Mannan oligosaccharides (MOS) are derived via partial hydrolysis of the
polysaccharide, mannan. The latter consist of α-1,4linked mannose monomers.
They are obtained commercially either from plant material or from yeast cell
walls. MOS are widely used in cattle, swine, and poultry feed.(Dimitroglou et al.
2009) They have been shown to improve gut function and health by increasing
the integrity, uniformity and height of the villi, which results in a higher absorption
efficiency in the gastrointestinal tract. (Iji et al. 2001; Hooge 2004; Castillo et al.
2008; Spais et al. 2003; Sims et al. 2004) Supplementation of poultry diets with
MOS has shown a positive response in body weight and feed conversion;
especially with cage-housed commercial broiler chicks (Kumprecht et al. 1997).
In addition, a study by Savage et al. 1996 showed that inclusion of MOS at 1 g/kg
diet enhanced both IgG and IgA serum antibody levels in turkey poults. The
benefits obtained from diet supplementation with MOS are attributed with several
factors, including modification of the intestinal microflora of the animals (Shane et
al. 2001).
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Pectic oligosaccharides (POS)
Pectins are complex polysaccharides that represent one of the major
components of the plant cell wall of dicotyledonous plants (Willats 2000;
Mandalari et al. 2006). They are considered soluble dietary fiber and exert
physiological effects on the gastrointestinal tract consistent with other fibers, in
that they delay gastrointestinal emptying (Flourie et al. 1985), reduce gut transit
time (Spiller et al. 1980), and reduce glucose absorption rates (Jenkins et al.
1977). Pectic oligosaccharides (POS) are formed via enzymatic hydrolysis of
pectins. Pectin is a heteropolysaccharide and contains several sugars, but the
primary monomers are α-1,4-linked galactosyluronic acid residues. The
enzymatically generated POS have been reported in several in vitro studies to
have prebiotic activity (Manderson et al. 2005; E. Olano-Martin et al. 2002),
based on increases in bifidobacteria.
Chitooligosaccharides (COS)
Chitin is a linear polysaccharide consisting of β-1, 4 linked N-acetyl-Dglucosamine residues. It is considered as one of the most abundant
polysaccharides in nature, after cellulose. It is mainly found in the cell walls of
fungi and yeasts and the exoskeleton of arthropods and insects (Aam et al. 2010;
Minke et al. 1978). Partial deacetylation of chitin yields chitosan, a
heteropolymer of N-acetyl-D-glucosamine and D-glucosamine residues.
Chitooligosaccharides (COS) are oligomers that can be obtained from chitosan
either chemically or enzymatically via synthesis with glycosyl hydrolases (Aam et
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al. 2010). Although the prebiotic activity of COS remains unclear, reports have
indicated that COS has antimicrobial activity mediated, in part, by adherence
inhibition (Rhoades et al. 2006; Xia et al. 2011).
The antiadherence model
Attachment of pathogenic bacteria to host cell surfaces is the first and in
many cases, one of the most important steps that occur during the infection
process (Klemm et al. 2010; Bavington et al. 2005; Shoaf et al. 2006). Bacterial
adhesion is mediated by several different physical and biological processes, as
shown in Figure 1. In general, physical forces influence the proximity of the
bacteria to the surface of the host cell only up to about 5 nm (Busscher 1987). A
much stronger and mostly irreversible complex is then formed between specific
bacterial adherence proteins and complementary host receptors (Pinzón-Arango
et al. 2009; Abu-Lail et al. 2003). These specific interactions are mediated
primarily by lectin-like molecules that recognize specific carbohydrates located at
the surface of epithelial cells. Lectins are defined as structurally diverse,
carbohydrate-binding proteins. Bacterial lectins are organized as thin-thread-like
organelles called fimbriae or pili (Bavington et al. 2005; Klemm et al. 2010;
Sharon 2006). The structural differences between different lectins are based on
a small globular carbohydrate-recognition domain; slight chemical differences in
these domains allow for the selectivity of each adhesin to its target receptor
(Shoaf-Sweeney et al. 2008; Weis et al. 1996). Thus, the specificity of a
pathogen for a particular tissue or host is dependent on the type of
oligosaccharide receptors coating the epithelial cell surface (Shoaf-Sweeney et
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al. 2008). Bacterial attachment not only enables the organism to avoid
displacement by the host’s natural cleansing mechanisms (e.g., peristalsis, bile
acid excretion, flux, etc.), but also provides access of the organism to sources of
nutrients located at the epithelial cell surface. Ultimately, bacterial adherence
promotes the organism’s potential for colonization and infection (Sinclair et al.
2009). Bacteria that are incapable of expressing functional adhesins are not able
to adhere and initiate infections, suggesting that adherence for these bacteria is
an essential step in pathogenesis (Boddicker et al. 2002; Cleary 2004).
Importantly, these observations imply that agents that block the initial attachment
of potential pathogens to host cell surfaces could significantly reduce or prevent
bacterial infections (Ziegler et al. 2007).

Figure 1. Bacterial adhesion involving lectin-carbohydrate interactions:
bacterial lectin-host glycoprotein (A1); bacterial lectin-host glycolipid (A2);
host lectin-bacterial LPS (A3); hydrophobin-protein interactions (B);
protein-protein interactions (C). Adapted from Ofek et al. 2003.
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One group of substances that have been considered as anti-adherence
agents includes prebiotic oligosaccharides. Accordingly, they are proposed to
act as molecular decoys that mimic the carbohydrate binding sites recognized by
the pathogen. The model is based on the observation that certain prebiotic
oligosaccharides have similar structures to the ones found in the surface of
epithelial cells (Kunz et al. 2000; Shoaf et al. 2006). Once inside the GI tract, the
pathogen will recognize the prebiotic as a binding site, adhere, and be removed
from the system. Oligosaccharides that have been shown to have antiadherence activity include oligosaccharides derived from human milk, as well as
the commercial prebiotics, GOS, FOS, inulin, lactulose, and raffinose (Shoaf et
al. 2006). Plant extracts and other molecules have also been tested and reported
to have anti-adherence activity. Several of these will be briefly reviewed in the
next section.
Anti-adherent oligosaccharides from human milk
Human milk is not only a rich source of protein, fat, and other nutrients,
but it also contains a large carbohydrate fraction (7%) consisting of lactose and a
complex mixture of oligosaccharides (Zivkovic et al. 2010); between 5 and 23
g/L. (Kunz et al. 2000; Coppa et al. 1993). Many of these human milk
oligosaccharides (HMO) have similar structures to those carbohydrates found in
the surface of intestinal epithelial cells (Sharon et al. 2000; 2002). More than 130
different HMO’s (Kunz et al. 2000), are known to be produced during the first
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several months of lactation (Ben et al. 2004) More recent analyses have
identified as many as 200 molecular species in pooled human milk samples
(Zivkovic et al. 2010). The basic structure of HMOs is comprised of lactose at the
reducing end, extended by N-acetyllactosamine units. The structural diversity is
granted by fucose and sialic acid residues at the terminal positions (Zivkovic et
al. 2010). The structures of the identified HMO’s consist of neutral and acidic
oligosaccharides, terminated by fucose (50 – 70%) and sialic acid (5 -15%).
(Ninonuevo et al. 2006) When tested in vitro, HMO have been reported to have
high affinity for bacterial adhesins (Newburg 2000; Miller et al. 1994; Newburg et
al. 2004; Kobata 2003). They have been reported to inhibit adhesion of
Escherichia coli, Vibrio cholerae, and Salmonella fyris to a Caco-2 tissue culture
cell line (Coppa et al. 2006). Other studies have reported that HMO inhibit
adherence of Campylobacter jejuni (Ruiz-Palacios et al. 2003), Streptococcus
pneumoniae and Haemophilus influenzae to human cell lines (Andersson et al.
1986). Despite their effectiveness as antiadhesives agents, they are obviously
are not food grade and cannot be used as food ingredients.
Galactooligosaccharides as anti-adherent agents
Commercially available GOS has been tested for antiadherent activity
against several enteric pathogens. Studies have shown that GOS inhibits the
adherence of Escherichia coli, Salmonella enterica serovar Typhimurium and two
different strains of Cronobacter sakazakii to tissue culture cells at a concentration
of 16mg/ml (Shoaf et al. 2006; Quintero et al. 2011; McGowan et al. 2011
manuscript in preparation) and suggested that anti-adherent activity against E.
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coli seems to be dose dependant until it reaches a plateau at a concentration of
16 mg/ml. Searle et al. also reported adherence inhibition of S. typhimurium by
GOS in a mouse model (Searle et al. 2009).
Mannan oligosaccharides as anti-adherent agents
It is well known that the Type 1 fimbriae from Salmonella sp. and
Escherichia coli are mannose-sensitive, in that free mannose is capable of
inhibiting adherence of these bacteria, as well as other pathogens, to host
tissues (Firon 1982; Neeser et al. 1986; Old 1972; Salit 1977; Kisiela et al. 2006)
Ganan et al. 2009 reported that yeast derived mannoproteins inhibit adherence
of Campylobacter jejuni to a Caco-2 cell line. Their results indicated that the
availability of mannose in the mannoprotein fraction seemed to be highly
important for inhibiting adherence and invasion. Furthermore, protective effects
with dietary mannose were also reported against Campylobacter jejuni
colonization in chickens (Schoeni et al. 1994). Other studies have shown that
adherence of Escherichia coli to epithelial cells can be inhibited or reversed by
the addition of mannose and it derivatives.(Ofek et al. 1978) Moreover, α-Dmannopyranoside has been shown to prevent urinary tract infection in mice by
inhibiting adherence and further colonization of the urinary tract by E. coli
(Aronson et al. 1979). Another study showed that chicks challenged with
Salmonella typhimurium had decreased cecal colonization when mannan
oligosaccharides were added to their diet (Spring et al. 2000).
Pectic oligosaccharides as anti-adherent agents
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Pectic oligosaccharides have been reported to inhibit invasion of
Campylobacter jejuni to Caco-2 cells in a dose dependent manner. (Ganan et al.
2010). Olano-Martin et al. 2003 assessed the ability of pectic oligosaccharides to
neutralize Escherichia coli Shiga toxins at various doses. A concentration of 10
mg/ml was reported to completely inhibit Shiga toxin 1 and Shiga toxin 2.
Despite these results, however, further research is needed to determine
antiadherence properties against other pathogens.
Other anti-adherent agents
In addition to oligosaccharides, some plant extracts and glycoproteins
have been reported to have antiadherence activity. Some of the mechanisms by
which they inhibit bacterial adherence have been well studied, while others need
further research. Of particular interest is the large molecular weight fraction from
cranberry concentrate and lactoferrin, a glycoprotein found in high concentrations
in milk.
Anti-adherent properties of cranberry
Cranberry juice has been consumed for decades for the purpose of
treating and preventing urinary tract infections. Urinary tract infections (UTI) are
one of the most prevalent diseases among females; approximately eight million
people per year experience UTIs in the U.S. (Cohn et al. 2004). They are most
often caused by Gram-negative bacteria, primarily uropathogenic Escherichia coli
(UPEC) (Johnson 2003). Although UTIs can usually be treated successfully with
antibiotics, when infections become recurrent, there is a growing concern about
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antibiotic resistance (Liu et al. 2006; Wilson et al. 2004). Recently, oral
consumption of cranberry products was reported to reduce UTI’s (Raz et al.
2004). The ability of cranberry to reduce or prevent infections caused by UPEC
has been attributed to the presence of two different compounds in cranberry
products; a high molecular weight component and proanthocyanidins (PACs).
Both were reported to inhibit adhesion of UPEC to uroepithelial cells (Rahbar et
al. 2010). Zafriri et al. 1989 reported that the non-dialyzable material of a
cranberry cocktail inhibited the activity of a mannose-specific Type 1 fimbriated
E. coli. This was assayed by yeast aggregometry, hemagglutination, adherence
to tissue culture cells, and attachment to mouse peritoneal macrophages. The
mechanism by which cranberry inhibits adhesion is poorly understood, although it
has been reported that some components interact directly with P-fimbriae by
altering their conformation and by binding of hydrophilic components, hence
inhibiting adherence (Liu et al. 2006). Interestingly, Sobota 1984 reported that
urine from mice and human still contained components that reduced E. coli
adherence after the consumption of cranberry products, suggesting that the
active compounds might not be destroyed during digestion. Other studies, both
in vitro and in vivo, have shown that cranberry juice constituents inhibit adhesion
of Helicobacter pylori (Burger et al. 2000; Burger et al. 2002; Shmuely et al.
2004). Furthermore, the high molecular weight component in cranberry juice has
been shown to reduce salivary Streptococcus mutans in a randomized controlled
population (Weiss et al. 2004). The effect was attributed to the ability of the
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HMW component to inhibit adhesion and biofilm formation of Streptococcus onto
tooth surfaces. (Steinberg et al. 2005; 2004; Weiss et al. 2004)
Anti-adherent properties of lactoferrin
Lactoferrin is an iron-binding protein that is found in high concentrations in
human milk and in lower concentrations in other fluids (Legrand et al. 2005). It
can be found in human colostrum in concentrations up to 7g/l, (Masson et al.
1971) and up to 1 mg/ml in human milk after the first month of lactation. In bovine
colostrum, it can reach up to 1.5 mg/ml. (Theresa J Ochoa et al. 2009). It is a
very stable protein and is highly resistant to proteolytic degradation (Lönnerdal
2009). Lactoferrin can be recovered in the stool of breast fed infants, indicating it
is at least partially resistant to digestion in the gut (Davidson et al. 1987).
Several biological functions have been attributed to lactoferrin, including
antimicrobial, anti-inflammatory, and immunomodulatory activities (Brock 2002;
Kruzel et al. 2002; Ward et al. 2002; Legrand et al. 2008; Actor et al. 2009). One
of the first mechanisms that account for the antimicrobial properties for lactoferrin
was based on its ability to sequester iron, thus depriving pathogens from this
essential nutrient (Bullen et al. 1972; Arnold et al. 1980; Nicola Orsi 2004).
Although lactoferrin is effective against several pathogens, this activity is
markedly reduced upon iron supplementation (Arnold et al. 1980; Kalmar et al.
1988; Yamauchi et al. 1993; Valenti et al. 2005). There are also ironindependent mechanisms by which lactoferrin inhibits pathogens, specifically via
the direct interaction of lactoferrin with bacterial cell surfaces (Dalmastri et al.
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1988; Carol A. Bortner, Roland R. Arnold 1989). Lactoferrin binds the lipid A
component of the lipopolysaccharide (LPS) in Gram-negative bacteria, affecting
membrane permeability, (Appelmelk et al. 1994; Brandenburg et al. 2001;
Shahriar et al. 2006) and thus releasing LPS from the membrane (Appelmelk et
al. 1994; Brandenburg et al. 2001; Ellison et al. 1988).
Several other iron-independent activities of lactoferrin exist that exert an
antimicrobial effect. It has been demonstrated that lactoferrin has a serine
protease-like activity and it is able to proteolytically degrade two colonization
factors expressed by Haemophilus influenzae, attenuating its virulence and
preventing colonization (Qiu 1998; Jenssen et al. 2009). Lactoferrin may also
interfere with the Type III secretory system that is used by many pathogenic
bacteria to adhere and infect host cells (Ochoa et al. 2003; DeVinney et al. 1999;
Goosney et al. 1999). Studies have shown that lactoferrin is able to degrade
virulence proteins secreted by Shigella flexeneri, resulting in inhibition of bacterial
uptake into host cells (Gomez et al. 2001; Gomez et al. 2003). A similar result
was observed with enteropathogenic Escherichia coli, where lactoferrin caused
loss and degradation of several Type III secretion proteins, resulting in reduced
bacterial virulence and adherence to host cells (Ochoa et al. 2003). Additionally,
enterotoxigenic Escherichia coli (ETEC) strains were reported to bind a
significant amount of lactoferrin (Naidu et al. 1991; Giugliano et al. 1995), which
may have accounted for the adherence inhibition observed for ETEC on HEp-2
tissue culture cells (Giugliano et al. 1995). Similarily, Bessler et al. 2006 reported
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that the direct interaction of lactoferrin with the bacterial surface inhibits
adherence and invasion of Salmonella typhimurium.
Prebiotics as therapeutic agents against the emerging pathogen
Cronobacter sakazakii
Infections caused by foodborne pathogens continue to be a major concern
to the food industry, consumers, and public health authorities. Often these
infections are self-limiting, but even for more serious cases, few therapies are
available. In general, even antibiotics are often of limited value. Research
efforts aimed at identifying new therapeutic or prophylactic strategies are
attracting considerable attention. Targets for such approaches include not only
pathogens, such as Escherichia coli and Salmonella spp., that have long been
associated with foodborne disease, but also recently recognized pathogens, such
as Cronobacter spp.
The genus Cronobacter is located within the family of the
Enterobacteriaceae. They are motile, non-sporeforming, rod shaped, Gram
negative facultative anaerobes (Chenu et al. 2009). It now appears that all
Cronobacter species are opportunistic pathogens (Johler et al. 2010; Hartmann
et al. 2010). Some species, in particular, Cronobacter sakazakii, are responsible
for causing rare, but severe forms of meningitis, sepsis and necrotizing
enterocolitis (NEC) in newborn infants and neonates (Acker et al. 2001; Hunter et
al. 2008; Muytjens et al. 1983; Biering et al. 1989; Bar-Oz et al. 2007). The infant
mortality rate due to infection of this organism has been reported to be 40 – 80%,
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and up to 20% of neonates that survive develop serious neurological
complications (Iversen et al. 2003). Although there is little information about the
natural reservoir of this organism, it has been isolated from food processing
plants and food products, including cheese products, cured meats, vegetables,
and herbs and spices. However, it is the association of C. sakazakii with
powdered infant formula (PIF) that has attracted the most concern. Indeed, PIF
has been implicated in several outbreaks (Forsythe 2005) and sporadic cases of
C. sakazakii infections (Iversen et al. 2003). Powdered infant formula is now
recognized as one of the main food sources for this organism (Iversen et al.
2004; Weir 2002; Drudy et al. 2006; Mullane et al. 2006; Iversen 2004; Iversen et
al. 2003). In addition, the organism has been isolated from powdered milk
processing plants as well as hospital utensils (spoons and blenders) used to
prepare infant formula (Forsythe 2005).
Several factors contribute to the ability of C. sakazakii to persist in dry milk
and PIF products. The organism has a remarkable resistance to osmotic stress
and desiccation, compared with other members of the Enterobacteriaceae, and
can persist under desiccated conditions in infant formula for over two years
(Breeuwer et al. 2003; Caubilla-Barron et al. 2007). Additionally, it produces a
yellow pigment that may protect the cells against UV rays and also has the ability
to form capsules and fimbriae that enable the organism to adhere to different
surfaces (Mullane et al. 2006). These physiological characteristics not only
enhance survival in the food production environment, but may also contribute to
persistence in other environmental sources such as water, soil, and vegetables.
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Although the incidence of Cronobacter infections is unknown, CDC has
estimated infection rates as low as 3 cases per year, worldwide. However,
because Cronobacter infections are most likely to involve newborn infants and
neonates,with mortalities rates as high as 40%, the organism is still considered a
serious public health threat. The infectious dose has not been established
although the Food and Agriculture Organization / World Health Organization
(2004) has determined a tentatively oral infectious dose that ranges from 103
CFU to 108 CFU.
The means by which C. sakazakii causes disease has only recently been
investigated. The organism appears to be able to trespass the intestinal barrier
and establish a systemic infection (Kim et al. 2008). Kothary et al. 2007
determined that Cronobacter synthesizes a zinc-containing metalloprotease that
has collagenolytic activity that allows the organism to cross the blood-brain
barrier. Hunter et al. 2008 suggested an association of Cronobacter with human
NEC, an inflammatory intestinal disorder that affects 2%-5% of neonates and that
has very high mortality rates. In mammalian tissue culture, the organism has
been shown to adhere to host cells and survive internally in macrophages
(Pagotto et al. 2003). However, the specific bacterial virulence factors implicated
in the process are still unknown (Mittal et al. 2009). An outer membrane protein
A (OmpA) of C. sakazakii is also thought to play an important role in the
attachment and invasion of Caco-2 cells (Kim et al. 2008). In general, invasion
was directly correlated with cell contact time and MOI, suggesting that entry of
the bacterium to Caco-2 cells may be receptor mediated and that C. sakazakii
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invasion is an active process that requires bacterial de novo protein synthesis.
The latter might be an important feature in systemic infection of neonates and
infants due to their lack of a fully established gut epithelial lining and the normal
microbiota (Kim et al. 2008). In contrast, another study demonstrated that C.
sakazakii binds to rat intestinal epithelial cells without significant invasion (Hunter
et al. 2008).
Conclusion
Prebiotic oligosaccharides are now commonly being used as food ingredients in
many food products. Several commercial prebiotics have been shown to
mediate changes in the intestinal microbiota of the host, in particular, a
bifidogenic effect when consumed on a regular basis. Some prebiotics may also
be able to directly inhibit infections caused by pathogenic bacteria via an antiadherence mechanism. This latter activity has led investigators to consider
adding anti-adherence prebiotics to powdered infant formula as a way to
prophylactically reduce or prevent infections caused by C. sakazakii. In addition,
the ability of other novel prebiotics and natural plant or milk-derived materials
may also have anti-adherent effects against pathogenic bacteria. However,
further research will be necessary to determine the feasibility of this approach.
The objectives of the research described in this thesis were to: (1)
determine the ability of GOS alone and in combination with other selected
commercial prebiotics to inhibit adherence of C. sakazakii to tissue culture cells;
(2) to determine the ability of plant extracts such as a cranberry extract and
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different oligosaccharides to inhibit adherence of enteropathogenic and
enterohemorragic Escherichia coli, and Salmonella enterica serovar
Typhimurium to tissue culture cells; (3) finally, to test the ability of lactoferrin to
inhibit adherence of C. sakazakii, alone and in combination with two
commercially available prebiotics, to tissue culture cells.
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Chapter 2
Adherence Inhibition of Cronobacter sakazakii to intestinal epithelial cells
by prebiotic oligosaccharides.
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Abstract
Cronobacter sakazakii is an opportunistic pathogen that has been implicated in
meningitis, NEC, and sepsis in neonates. Colonization and subsequent infection
and invasion of C. sakazakii require that the organism adhere to host cell
surfaces. Agents that inhibit or block attachment of the pathogen to epithelial
cells could be useful in reducing infections. The goal of this research was to
assess the ability of prebiotic galactooligosaccharides (GOS) and polydextrose
(PDX) to inhibit adherence of C. sakazakii 4603 to a HEp-2 human cell line.
Adherence experiments were performed in the presence or absence of prebiotics
using HEp-2 cells grown to confluency on glass coverslips. Prebiotics and
bacteria were added and incubated for 3 hours. Coverslips were washed and
adherence was determined by cultural and microscopic methods. When
measured microscopically or by cultural methods, significant reductions in
adherence (56% and 71%, respectively) of C. sakazakii were observed in the
presence of GOS (16 mg/ml). Adherence inhibition also occurred (48%) when a
GOS-PDX blend (8 mg/ml each) was tested, although PDX by itself had less
effect. Similar results were also observed for Caco-2 cells and also for another
strain of C. sakazakii (29004).
These results suggest that GOS and PDX, alone and in combination, may have
an anti-adhesive effect on C. sakazakii and directly inhibit the adherence to
gastrointestinal epithelial cells.
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Introduction
Prebiotics were defined originally as food ingredients that provide beneficial
effects for the host by selectively stimulating the growth and/or activity of one or a
limited number of bacteria in the colon [10]. In recent years, prebiotics have
been reported to have additional biological activities, beyond their influence on
the gut microbiota. Specifically, it has been suggested that some prebiotics, in
particular, galactooligosaccharides (GOS), may be able to inhibit gastrointestinal
infections via anti-adhesive activities [9,26,30]. This concept is based on the
observation that for most pathogens, the initial adherence to host cell surfaces is
one of the first steps prior to colonization and infection. Adherence is most
commonly mediated via lectin-like adhesins expressed by the bacteria that
recognize and adhere to ligand-like carbohydrates located on the surface of the
host epithelial cells. Bacterial variants that are unable to express functional
adhesins are unable to adhere and initiate infections, indicating that adherence is
required for pathogenesis [1,4,14]. Thus, agents that inhibit adherence could
potentially reduce infections [29,35].
The anti-adherence strategy depends on the structural similarity between the
carbohydrate binding sites ordinarily recognized by pathogens and the
exogenous prebiotic oligosaccharides. The latter would compete with the
cognate sugars for binding to the adhesin and thereby inhibit bacterial adherence
[27,30]. Indeed, in human milk there are many oligosaccharides that contain
residues and linkages similar to those found on the surface of intestinal epithelial
cells [18,28]. These human milk oligosaccharides (HMO) have high affinity for
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bacterial adhesins, which likely contribute to the anti-adherence properties of
human milk. Several recent studies have reported that food-grade
oligosaccharides that are currently marketed as prebiotics, also have antiadhesive activity [27,31,32]. In these studies, food-grade forms of GOS inhibited
adherence of Eschericia coli and Salmonella enterica serovar Typhimurium to the
surface of tissue culture cells and also inhibited Vibrio cholerae toxin binding to
the cell surface toxin receptors. Commercial GOS is comprised of several
galactose-containing species of varying lengths, and although this GOS lacks
sialic acid and other functional groups ordinarily present in human milk
oligosaccharides, at sufficient concentrations they nonetheless have adherence
inhibition activity [31]. Another commercial carbohydrate that has been proposed
to have prebiotic activity is polydextrose (PDX), a polysaccharide composed of
randomly cross-linked glucose units [23]. PDX resists small bowel enzymes and
is fermented more slowly by intestinal bacteria versus other non-digestible
oligosaccharides [25]. Its anti-adhesive activity, however, has not yet been
studied.
Cronobacter sakazakii (formerly Enterobacter sakazakii) is now recognized as an
emerging opportunistic pathogen and has been implicated in severe forms of
meningitis, necrotizing enterocolitis (NEC), and sepsis in neonates [3,16,24].
The infant mortality rate due to infection by this organism has been reported to
be 33 – 80%, with up to 20% of surviving neonates developing serious
neurological complications [19]. Therefore, prophylactic efforts to mitigate
neonatal infections caused by this organism are of considerable interest [11,12].
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The main goal of this research, therefore, was to assess the ability of
galactooligosaccharide (GOS) and polydextrose (PDX), as well as a blend of
GOS and PDX, to inhibit adherence of C. sakazakii to a human cell line.
Materials and Methods

Organisms and growth conditions. Strains of C. sakazakii used in this study
are described in Table 1 and were obtained from K. Venkitanarayanan
(Department of Animal Science, University of Connecticut). Prior to each
experiment, frozen stock cultures of each organism were thawed, plated onto
Tryptic Soy Agar (TSA; Difco) and grown overnight at 37°C. A single colony was
inoculated into 10 ml of Tryptic Soy Broth (TSB; Difco) and incubated aerobically,
without shaking. Preliminary experiments revealed that adherence rates were
highest when cells were in late log phase. Therefore, after 6 hour incubation,
cultures were harvested by centrifugation (3,184 x g for 8 minutes). The cells
were washed once with phosphate-buffered saline (PBS) and re-suspended in
minimal essential medium (MEM; Hyclone, Logan, Utah), supplemented with
10% fetal bovine serum (FBS; Hyclone). Minimal essential medium was preequilibrated at tissue culture conditions (5% CO2, 95% relative humidity, 37°C).
Based on additional preliminary experiments, two strains (4603 and 29004)
repeatedly gave the highest adherence rates on HEp-2 cells and were used for
all subsequent experiments.
Prebiotics (GOS and PDX). Galactooligosaccharide (GOS; Friesland Foods
DOMO, Zwolle, the Netherlands) was obtained as a 70% concentrated syrup and
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was lyophilized to give a final product of 95% total solids. The GOS
concentration, based on the manufacturer’s information, was 60% (containing
mainly chains of 3-6 monomers in the ∃1-4 form), with the balance as lactose,
glucose, and galactose. Polydextrose (PDX), obtained from Danisco (New
Century, KS), had an average degree of polymerization (DP) of 12 and an
average molecular weight of 2000 [7]. The GOS and PDX were prepared as
concentrated stock solutions with distilled sterile water at a final concentration of
160 mg/ml. The solutions were filter sterilized using 0.22 µm filters. A 1:1 blend
of PDX and GOS was prepared by mixing equal volumes to give 80 mg/ml of
each.
Tissue culture cells. HEp-2 cells were obtained from the American Type
Culture Collection (ATCC; Manassas, Virginia). Cells were grown in 75 cm2
tissue culture flasks (Corning) containing 25 ml of MEM supplemented with 10%
FBS in a CO2 incubator at tissue culture conditions. Confluent Hep-2 cells were
harvested by adding 0.5 ml of 0.25% Trypsin-EDTA Solution (Sigma) and
incubating for 15 minutes at tissue culture conditions. Trypsin was inactivated
with 0.5 ml of FBS. Cells were then seeded onto 12-mm diameter glass
coverslips in 24-well tissue culture plates (Falcon) at approximately 3.6 x 105
viable cells per well, and 500 µl of MEM supplemented with 10% FBS was added
to each well. Plates were incubated under tissue culture conditions for two days
prior to the start of each experiment, or until confluency was reached. Media was
replaced one day before the experiment. Caco-2 cells (ATCC) were grown as for
HEp-2 cells except that the MEM was supplemented with 20% FBS. and the

61

cells were incubated for fourteen days prior to the start of each experiment, or
until confluency was reached. Media was replaced every other day and one day
before the experiment.
Adherence Assays. Cell suspensions of C. sakazakii 4603 and ATCC 29004 for
HEp-2 cells, and C. sakazakii ATCC 29004 for Caco-2 cells, were prepared as
described above. Prebiotics were mixed with bacterial cultures (in MEM
supplemented with FBS) prior to addition to the tissue culture cells. As a control,
water was added to the bacterial cultures at the same volume as the prebiotics.
The prebiotic solutions represented 10% of the final volume of the suspension,
giving a final concentration of 16 mg/ml of prebiotic in the assay mixtures. For
the GOS-PDX blend, the final concentration of each prebiotic was 8 mg/ml. The
plates were incubated for 3 hours at tissue culture conditions. Preliminary
experiments indicated that 3 hours of incubation were optimal for adherence of
the bacterial strains to the HEp-2 and Caco-2 tissue culture. The wells were then
washed 5 times with PBS to remove non-adhered bacterial cells. HEp-2
experiments were done in duplicate and replicated 5 times (n = 10) for
microscopic analyses and 3 times (n = 6) for cultural enumeration. The Caco-2
experiments were done in duplicate and replicated twice (n=4).
Microscopic enumeration. Adhered cells were fixed with 100% methanol for 20
minutes and stained with 10% Geimsa for 15 minutes. The slides were then
washed once with sterile distilled water and dried overnight at room temperature.
Coverslips were mounted on microscope slides and observed under a phase
contrast microscope with the 100x objective. Fifteen pictures of each coverslip
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were taken using Motic Image software following an established pattern
throughout the entire coverslip. The number of cells and bacteria in each picture
were counted using Image J image analysis software. Total adherence was
calculated as the number of adhered bacteria per tissue culture cell. Adherence
inhibition was calculated as the number of adhered bacteria per cell in the control
minus the number of adhered bacteria per cell in the treatment divided by the
number of adhered bacteria per cell in the control.
Culture enumeration. Cells were washed as described above and detached by
addition of 0.1% Triton X-100 for 30 minutes at room temperature. The cells
were collected and enumerated on Tryptic Soy Agar (TSA; Difco) after aerobic
incubation at 37°C for 24 hours. Adherence inhibition was calculated as the
number of adhered bacteria per ml in the control minus the number of adhered
bacteria per ml in the treatment divided by the number of adhered bacteria per ml
in the control.
Statistical Analysis. Significant differences between the treatments were
determined by analysis of variance (ANOVA) using PROC GLIMMIX in SAS
(version 9.2).
Results
GOS and PDX reduce adherence of C. sakazakii to HEp-2 cells Adherence
assays were conducted for all five strains of C. sakazakii on both cell lines (HEp2 and Caco-2). As other workers previously reported [20], we also observed that
some strains had higher adherence rates than others. Specifically, preliminary
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experiments (data not shown) showed that strains 4603 and 29004 gave the
most consistent results and were used for these studies. Subsequently,
adherence of C. sakazakii 4603 to HEp-2 cells in the presence and absence of
prebiotics was measured by microscopic and culture methods. Both methods
revealed that C. sakazakii 4603 adherence was significantly reduced when GOS
and the GOS-PDX blend was present (Figure 1). By microscopic examination,
GOS addition led to a 56% reduction of binding by C. sakazakii 4603 to the HEp2 cells. Similarly, a 48% reduction occurred in the presence of the GOS-PDX
blend. However, PDX by itself did not significantly reduce adherence, when
measured by microscopy (Figure 1A). Experiments with C. sakazakii ATCC
29004 gave similar results when measured microscopically, with reductions of
63% and 53% in the presence of GOS and the GOS-PDX blend, respectively,
(Figure 2). However, for this strain, the PDX significantly inhibited (42%)
adherence.
The cultural enumeration results confirmed those observed by microscopic
examination for both strains (Figures 1B and 2B). However, inhibition levels
were somewhat higher when the culture data was used to calculate adherence
inhibition. For strain 4603, GOS and the GOS-PDX blend reduced adherence by
71% and 49%, respectively. PDX also inhibited adherence by 55%. The GOS,
GOS-PDX, and PDX treatments reduced adherence of strain 29004 by 83%,
80%, and 58%, respectively. Photomicrographs of the coverslips provided
additional confirmation that adherence of C. sakazakii to HEp-2 cells was
reduced in the presence of GOS, PDX and the GOS-PDX blend (Figure 3).
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GOS and the GOS-PDX blend also inhibit adherence of C. sakazakii to
Caco-2 cells. Adherence of C. sakazakii ATCC 29004 to Caco-2 cells in the
presence and absence of prebiotics was measured by microscopic methods
(Figure 4). These experiments revealed that C. sakazakii 29004 adherence was
significantly lower when the GOS or GOS-PDX blend was present (31 and 38%
reductions, respectively). Although a 20% reduction in adherence was observed
for the PDX treatment, this reduction was not significant.
Discussion
The use of molecular decoys to reduce pathogen adherence to intestinal
epithelial cells and subsequently prevent infection by pathogenic agents was
proposed more than a decade ago [35]. However, only recently have food-grade
oligosaccharides, including those already used as prebiotics, been shown to
have anti-adhesive activity against enteric pathogens [27,31]. In these reports,
enteropathogenic E. coli and Salmonella enterica serovar Typhimurium were
inhibited in vitro and in mice by two different forms of GOS. These reports led us
to consider whether adherence inhibition by prebiotics extended to other enteric
pathogens, and C. sakazakii, in particular. Although the prevalence of C.
sakazakii in the environment and in foods is very low and infections are rare, the
morbidity rates are very high [8,15]. Therefore, efforts aimed at reducing
infections are warranted.
In this study, adherence inhibition of C. sakazakii to HEp-2 cells in the presence
of prebiotic carbohydrates was determined by two methods, direct microscopic
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counting and by cultural enumeration on agar plates. By both methods, the
results showed that GOS had an anti-adhesive effect on both of the strains of C.
sakazakii used in these experiments. The GOS used in these experiments also
contained lactose, glucose, and galactose; however, their contribution to
adherence was likely not significant, based on previous reports [5,21,31].
Although PDX also had anti-adherence activity, the effects were not significant in
all experiments (Figure 1A). In previous experiments, GOS had greater
adherence inhibition compared to all other tested oligosaccharides [31].
Similarly, in the experiments with Caco-2 cells, the adherence inhibition of C.
sakazakii 29004 by GOS was greater than PDX and equal to that of the blend.
Although the pathogenesis of C. sakazakii is still under investigation, it appears
to share the same initial steps in infection as other pathogens by adhering and
colonizing host surfaces [20,22]. It was previously suggested that this organism
adheres to host cell tissue by recognizing specific host cell targets [22], indicating
that an anti-adherence approach could be useful. However, adherence in C.
sakazakii was also suggested to be independent of fimbrae [20].
This is the first study in which PDX was compared to GOS in an anti-adherence
model. Previously, an in vitro analysis suggested that GOS is fermented
primarily in the proximal end of the large intestine, whereas PDX fermentation
occurs from the proximal to the distal end [13,25]. The fermentation of PDX
resulted in lower levels of short chain fatty acids (SCFA) compared to GOS,
suggesting that PDX may be less bifidogenic. In another in vitro study, PDX
resulted in lower E. coli counts, compared to other prebiotics, although the
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mechanism was not determined [33]. In adults, consumption of PDX improved
bowel functions, produced SCFAs, and promoted the proliferation of a favorable
intestinal microbiota [17]. Similarly, in an infant feeding trial with GOS and PDX,
the stool characteristics of infants receiving the prebiotic mixture were more
similar to those of breast-fed infants, in comparison to infants fed
unsupplemented formula [34].
Our results showed that PDX inhibited adherence of C. sakazakii on HEp-2 cells,
although it was generally less inhibitory than GOS, at the same concentration.
On Caco-2 cells, the PDX-GOS blend, each at 8 mg/mL, was as inhibitory as the
GOS alone (at 16 mg/mL), suggesting that additional research on the antiadherence properties of PDX might be warranted. Mange et al. [20] examined
the adherence properties of 50 C. sakazakii strains on three cell lines, including
HEp-2 and Caco-2 and reported that considerable heterogeneity existed within
strains. While mannose reduced diffuse adherence, cluster-mediated adherence
was unaffected. Thus, the specific means by which adherence occurred could
not be established. Apart from the differences between cells lines, the
adherence inhibition results seen in our study are also likely due to structural
differences between the galactose-containing GOS and the glucose-containing
PDX.
Conclusions
Collectively, our results showed that GOS and GOS-PDX blends effectively
reduced adherence of C. sakazakii in tissue culture experiments. Although GOS
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is chemically distinct from the human milk oligosaccharides that might be
expected to have even greater adherence inhibition [2,18,28], there is evidently
enough similarity between GOS and human milk oligosaccharides to be effective
at the concentrations used in this study. Consequently, in vivo supplementation
with GOS or GOS-PDX blends might parallel some of the functionalities of these
milk oligosaccharides. However, it should be noted that the concentration of
prebiotics used in this in vitro study exceeds the supplementation level generally
reported for commercial infant formula [6].
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Figure 1. Adherence of C. sakazakii 4603 to Hep-2 cells in the presence of
prebiotics (16 mg/ml). In A, adherence was measured by microscopic counting
(n = 10), and in B, adherence was measured by cultural enumeration (n = 6).
Statistically significant effects (p < 0.05) are indicated by the asterisk.

75

76

Figure 2. Adherence of C. sakazakii 29004 to Hep-2 cells in the presence of
prebiotics (16 mg/ml). In A, adherence was measured by microscopic counting
(n = 10), and in B, adherence was measured by cultural enumeration (n = 6).
Statistically significant effects (p < 0.05) are indicated by the asterisk.
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Figure 3. Adherence of C. sakazakii 4603 to Hep-2 cells in the absence (A) and
presence of GOS (B), GOS-PDX (C); and PDX (D).
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Figure 4. Adherence of C. sakazakii 29004 to Caco-2 cells in the presence of
prebiotics (16 mg/ml). Adherence was measured by microscopic counting (n = 4)
at 1000 x magnification. Significant effects (versus the control) are indicated by
the asterisk (p < 0.05).
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Table 1. Strains and Sources
Strain

Source

Cronobacter sakazakii 4593

Milk powder isolate (infant formula)

Cronobacter sakazakii 4603

Milk powder isolate (infant formula)

Cronobacter sakazakii 29004

ATCC (deposited by CDC)

Cronobacter sakazakii 4583

Enterocolitis isolate

Cronobacter sakazakii 415

Meningitis isolate
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Chapter 3
Adherence Inhibition of Intestinal Pathogens by Prebiotic Oligosaccharides
and Plant Extracts

84

Abstract
Although prebiotic oligosaccharides are well known for their ability to modulate
the intestinal microbiota, they have been shown to have other biological
activities. Specifically, oligosaccharides and plant extracts may also act as
molecular decoys that inhibit adherence of pathogens to the surface of epithelial
cells. The goal of this research was to assess the ability of several prebiotic
agents, including chitooligosaccharides (COS) and mannan oligosaccharides
derived from yeast cell walls (MOSy) and konjac root (MOSk), to inhibit
adherence of enteropathogenic Escherichia coli (EPEC), enterohemorragic
Escherichia coli (EHEC) and Salmonella typhimurium to a human HEp-2 cell line.
In addition, a high molecular weight component of cranberry (CHMW) was also
assessed for anti-adherence. Different fractions of COS significantly reduced
adherence of EPEC at a concentration of 16 mg/ml. Although MOSy inhibited
EPEC, EHEC, and S. typhumiurim, adherence inhibition was not observed for
MOSk. Adherence inhibition of EPEC, EHEC, and S. typhumiurim by CHMW
was observed. These results suggest that different oligosaccharides and plant
extracts may be promising therapeutic agents that could be added to foods in
order to prevent or mitigate bacterial adhesion to gastrointestinal epithelial cells.
Introduction
Prebiotics were originally defined more than 15 years ago as “nondigestible food ingredient(s) that beneficially affects the host by selectively
stimulating the growth and/or activity of one or a limited number of bacteria in the
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colon, and thus improves host health” (Gibson et al. 1995). Although this
definition has been modified slightly (M. Roberfroid 2007), to consider a
substance as a prebiotic still depends on the ability of that substance to effect
positive changes in the gut microbiota. Recently, however, some prebiotics have
been shown to possess another quite different biological activity that also
contributes to the health of the host. Specifically, certain prebiotic
oligosaccharides are able to interfere with the adherence mechanism used by
pathogenic bacteria to attach to the surface of target tissues, in the gut as well as
in extraintestinal tissues (Shoaf et al. 2006; Kunz et al. 2000). The model is
based on the structural similarity that different oligosaccharides have to the
receptors recognized by pathogens as binding sites. Since adherence is the first
and perhaps rate-limiting step in many bacterial infections, strategies based on
preventing or inhibiting adherence could be effective at reducing infections and
the subsequent onset of disease (Klemm et al. 2010; Bavington et al. 2005;
Shoaf et al. 2006).
Several commercial prebiotics have been assessed in vitro for their ability
to inhibit pathogen adherence to epithelial cells, including inulin,
galactooligosaccharides (GOS), and fructooligosaccharides (FOS). In particular,
GOS has been reported to inhibit adherence of Escherichia coli, Salmonella
enterica serovar Typhimurium and two different strains of Cronobacter sakazakii
to tissue culture cells (Shoaf et al. 2006; Quintero et al. 2011; McGowan et al.
2011, manuscript in preparation). In addition, other putative prebiotics extracted
from plant material have also been reported to have anti-adherence activity,
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including pectic oligosaccharides that were shown to reduce invasion of
Campylobacter jejuni to a Caco-2 cell line (Ganan et al. 2009).
One group of plant extracts that has long been studied for their ability to
prevent infections are cranberry extracts. Juices and cocktails obtained from
cranberries have been consumed for decades with the purpose of treating and
preventing urinary tract infections (Schaeffer et al. 2004). The high molecular
weight component of cranberry juice has been reported to inhibit the adhesion of
a mannose specific Type 1 fimbriated E. coli to tissue culture cells (Zafriri et al.
1989). Additionally, several studies have reported that cranberry juice
constituents inhibit adherence of Helicobacter pylori to the surface of epithelial
cells in vitro and in vivo. (Burger et al. 2000; Burger et al. 2002; Shmuely et al.
2004). Furthermore, cranberry has been shown to inhibit t the adhesion of oral
bacteria such as Streptococcus mutans onto tooth surfaces (Steinberg et al.
2005; 2004; Weiss et al. 2004).
Infections caused by enteric pathogens are commonly treated with
antibiotics. Although antibiotics have been very effective at reducing mortality
caused by bacterial infections, their use has also led to the appearance of
resistant strains (Davies et al. 2010). Therefore, efforts to develop new
approaches for preventing infections are a high priority among public health
experts. In this research, several different oligosaccharides and plant extracts
were evaluated for their ability to inhibit adherence of selected bacterial
pathogens to HEp-2 tissue culture cells.
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Materials and Methods
Organisms and growth conditions
Enteropathogenic Escherichia coli (EPEC) EPEC strain E2348/69 (O127:H6)
was obtained from M. Donnenberg (University of Maryland School of Medicine,
Baltimore). Before each experiment, frozen stock cultures of were plated onto
Tryptic Soy Agar (TSA; Difco) and grown overnight at 37°C. A single colony was
inoculated into 10 ml of Tryptic Soy Broth (TSB; Difco) and incubated overnight
at 37°C without shaking. Overnight cultures were then inoculated at 1% (vol/vol)
into Modified Eagle Medium (MEM; Hyclone) supplemented with 10% fetal
bovine serum (FBS; Hyclone) that was pre-equilibrated at tissue culture
conditions (5% CO2, 95% relative humidity, 37°C). Cells were then incubated in
MEM for 80 min at 37°C prior to the start of the experiment.
Salmonella enterica serovar Typhimurium Before each experiment, frozen
stock cultures of were plated onto Luria Bretani Agar (LB; Difco) and grown
overnight at 37°C. A single colony was inoculated into 10 ml of Luria Bretani
Broth (LB; Difco) and incubated for 23-24 hours at 37°C without shaking.
Cultures were then washed once with phosphate buffer saline (PBS) and
resuspended in pre-equilibrated MEM supplemented with 10% FBS.
Enterohemorragic Escherichia coli (EHEC) EHEC strain ATCC 43888
(O157:H7) was obtained from the American Type Culture Collection (ATCC;
Manassas, Virginia) and the same procedure for EPEC was followed.
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Prebiotics and Plant Extracts
Cranberry. Cranberry concentrate was obtained from Ocean Spray
Cranberries, Inc. The concentrate was used directly as concentrated material
following neutralization with 1M NaOH. The total solids concentration was
determined on a dry weight basis. The cranberry concentrate was also
fractionated by dialysis to yield a high molecular weight component (HMW).
Exhaustively dialysis was performed for 5 days at 4°C using 12,000 – 14,000
MW cut-off dialysis tubing against distilled water. The non-dialyzable material
was then freeze dried. A stock solution was prepared by resuspending the freeze
dried material in distilled water to a concentration of 10 mg/ml. The solution was
filter sterilized using 0.22-µm filters.
Chitin Oligosaccharides (COS). Different COS fractions (based on MW) were
obtained from Berit Bjugan Aam (Norwegian University of Life Science, Norway),
as freeze dried powders. Freeze dried material was resuspended in autoclaved
distilled water and final concentration of the stock solution was determined for
each fraction.
Konjac Mannan (MOSk). Konjac mannan was obtained from Wayne Muller
(United States Army NSRDEC, Natick, MA) as a dry powder. MOSk was
prepared as a concentrated stock solution with distilled water at a final
concentration of 160 mg/ml. The solution was filter sterilized using 0.22-µm
filters.
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Yeast Mannan (MOSy) Yeast mannan was obtained from Lallemand (Ontario,
Canada) as a powdered material. A stock solution was prepared dissolving 160
mg of powder per ml of distilled water. The solution was centrifuged at 201 x g for
10 minutes and the supernatant was saved. The supernatant was filtered
through a 0.4-µm filter and subsequently freeze dried. A stock solution was
prepared in distilled water at a final concentration of 200 mg/ml.
Tissue culture cells HEp-2 cells were obtained from ATCC. Cells were grown
in 75 cm2 tissue culture flasks (Corning) containing 25 ml of MEM supplemented
with 10% FBS in a CO2 incubator at tissue culture conditions. Confluent Hep-2
cells were harvested by adding 0.5 ml of 0.25% Trypsin-EDTA Solution (Sigma)
and incubating for 15 minutes at tissue culture conditions. Trypsin was
inactivated with 0.5 ml of FBS. Cells were then seeded onto 12-mm diameter
glass coverslips in 24-well tissue culture plates (Falcon) at approximately 3.6 x
105 viable cells per well, and 500 µl of MEM supplemented with 10% FBS was
added to each well. Plates were incubated under tissue culture conditions for 30
hours prior to the start of each experiment, or until confluency was reached.
Adherence Assays Cell suspensions of EPEC E2348/69 (O127:H6), Salmonella
enterica serovar Typhimurium, and EHEC were prepared as described above.
Prebiotics were mixed with bacterial cultures (in MEM supplemented with FBS)
prior to addition to the tissue culture cells. As a control, water was added to the
bacterial cultures at the same volume as the prebiotics. The prebiotic solutions
were prepared at different concentrations depending on the product used. The
plates were incubated for 30 minutes for EPEC E2348/69 (O127:H6) and
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Salmonella enterica serovar Typhimurium, and 90 minutes for EHEC. The wells
were then washed 5 times with PBS to remove non-adhered bacterial cells.
Experiments were done in duplicate and replicated 3 times (n=6) for analysis with
quantitative real time PCR (qRT-PCR) and 2 times for microscopic analyses
(n=4).
Quantitative Real Time PCR (qRT-PCR). Bacterial cells from adherence
assays were detached by the addition of 1 ml of 0.1% Triton X-100 for 30
minutes at room temperature. Bacterial cells were harvested and centrifuged for
5 min at 10,000 x g, supernatant was discarded and pellet was resuspended in
180 µl of buffer ATL from the DNeasy Blood and Tissue Kit (Qiagen, Hilden,
Germany). Instructions provided in the manufacturer’s manual for DNA
extraction of Gram negative bacteria were followed to complete the extraction.
Quantitative real time PCR (qRT-PCR) was performed using a Mastercycler
Realplex2 (Eppendorf AG, Hamburg, Germany). Each PCR was done in a 25 µl
volume. The reaction mixture comprised 11.25 µl of the 20x SYBR solution and
2.5-µl Real-MasterMix (5Prime), 0.5 µM of each primer, and 1 µl of DNA
template. (Martínez et al. 2009) Specific primers and amplification program were
followed for each organism.
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Table 1. Primers and PCR programs for the different organisms used in this
study.
Table 1.
Organism

Primers (5’ - 3’)

Amplification Program

EPEC and

eaeFor GGCGATTACGCGAAAGATAC

Initial denaturation at 95°C for 10

EHEC

eaeRev GATTAACCTATGCCGTTCCA

min and 40 cycles at 95°C for 15s
and 62°C for 1 min for annealing
and extension.

Salmonella

139 -GTGAAATTATCGCCACGTTCGGGCAA

Initial denaturation at 94°C for 2

141 -TCATCGCACCGTCAAAGGAACC

min and 45 cycles at 94°C for 20s
and 62°C for 1 min for annealing
and extension

Microscopic enumeration Adhered cells were fixed with 100% methanol for 20
minutes and stained with 10% Geimsa for 15 minutes. The slides were then
washed once with sterile distilled water and dried overnight at room temperature.
Coverslips were mounted on microscope slides and observed under a phase
contrast microscope with the 100x objective. Fifteen pictures of each coverslip
were taken using Motic Image software following a pre-established pattern
throughout the entire coverslip. The number of cells and bacteria in each picture
were counted using Image J image analysis software. Total adherence was
calculated as the number of adhered bacteria per tissue culture cell. Adherence
inhibition was calculated as the number of adhered bacteria per cell in the control
minus the number of adhered bacteria per cell in the treatment divided by the
number of adhered bacteria per cell in the control.
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Statistical analysis Significant differences between the treatments were
determined by one way analysis of variance (ANOVA) using Tukey to compare
all pairs of columns with alpha = 0.05. GrpahPad Prism5 software was used to
perform statistical analysis.
Results
Cranberry concentrate reduces adherence of EPEC and Salmonella
Typhimurium to HEp-2 cells. Adherence of EPEC and Salmonella typhimurium
in the presence and absence of a neutralized cranberry concentrate to HEp-2
cells was measured by qRT-PCR (Figure 2). Experiments revealed that the
neutralized cranberry concentrate inhibited adherence of EPEC and S.
typhimurium at a minimum concentration of 25 and 10 mg/ml, respectively.
Cranberry High Molecular Weight Component reduces adherence of EPEC,
EHEC, and Salmonella Typhimurium to HEp-2 cells. Adherence of EPEC,
EHEC and Salmonella Typhimurium in the presence and absence of a cranberry
HMW component to HEp-2 cells was measured by qRT-PCR and by microscopic
enumeration (Figure 1). Both methods revealed that the HMW component of
cranberry inhibits adherence of EPEC (A,B), Salmonella typhimurium (C, D), and
EHEC. (E, F)
COS inhibits adherence of EPEC to HEp-2 cells. Adherence of EPEC in the
presence and absence of different fractions of chitin oligosaccharides to HEp-2
cells was measured by microscopic examination (Figure 3). At a concentration of
16 mg/ml, COS fraction KN + C88 (A) inhibited adherence by 93%, fraction
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W275A (C) reduced adherence by 72%, FA 0.15(NC) reduced adherence by
76% and fraction FA 0.61 reduced adherence by 74%.
MOSk does not inhibit adherence of EPEC, EHEC, and Salmonella
Typhimurium to HEp-2 cells. Adherence of EPEC, EHEC, and Salmonella
typhimurium in the presence and absence of MOSk to HEp-2 cells was
measured by qRT-PCR and microscopic counting (Figure 4). Both methods
revealed there was no inhibition of EPEC, EHEC, or Salmonella typhimurium by
MOSk.
MOSy inhibits adherence of EPEC and Salmonella Typhimurium to HEp-2
cells. Adherence of EPEC, EHEC and Salmonella typhimurium in the presence
and absence of MOSy to HEp-2 cells was measured by qRT-PCR and
microscopic examination (Figure 5). Both methods revealed that MOSy inhibits
adherence of EPEC and Salmonella typhimurium. Results show no significant
reduction in adherence of EHEC to HEp-2 cells.
Discussion
The use of molecular decoys to prevent pathogen adherence was
proposed more than a decade ago (Ebrahim 1997; Andersson et al. 1986;
Cravioto et al. 1991; Ofek et al. 1978). In recent years, several oligosaccharides,
including food and non-food grade materials, have been tested for their antiadherence effects against different pathogens. Extracts from plants and other
naturals sources have also been studied for their anti-adherence activities. In
this report, we compared five different novel oligosaccharides and plant extracts
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for their ability to prevent or inhibit adherence of EPEC, EHEC, and S.
typhimurium to the surface of epithelial cells. The results showed that while
some of the test materials were very effective, other agents had little ability to
inhibit adherence.
Cranberry juice consumption has long been promoted for its putative
therapeutic activities, and especially for preventing or treating urinary tract
infections (Schaeffer 2004). It was reported that the maximum adherence
inhibition of Helicobacter pylori to gastric mucus was at a concentration of 1
mg/ml (Burger et al. 2000). Similarly, it was also reported that cranberry juice
cocktail reduced adherence of E. coli isolates from patients with UTI by more
than 75% (Sobota 1984). The mechanism by which cranberry inhibits adhesion is
poorly understood, although it has been reported that the high molecular weight
component might directly interact with P-fimbriae by altering the latter’s
conformation and also by binding hydrophilic components (Y. Liu et al. 2006).
Our results when using neutralized cranberry concentrate and the HMW
component show inhibition of enteric pathogens such as Salmonella
typhimurium, EPEC and EHEC to intestinal epithelial cells. These results suggest
that consumption of cranberry juice might be helpful in preventing infections
caused by the latter organisms.
Chitosan derivatives have several applications in the food industry, and
one of the most important properties is their antimicrobial activity; (Xia et al.
2011; Tsai et al. 2002) the latter has been reported to be, to a certain extent, by
inhibiting bacterial adherence. (Rhoades et al. 2006; Xia et al. 2011) Four
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different fractions of chitin oligosaccharides were tested in this study; they all
showed bacterial adherence inhibition higher than 70%. Growth of the organism
in TSB with COS at the same concentration was also measured to determine if
COS had a general bactericidal effect; no inhibition was observed (data not
shown). Thus, COS appears to have significant antiadherent activity, although
further research is needed to establish how stable and safe this material is before
it could be added as a food ingredient.
Mannan from konjac root did not inhibit adherence of any of the organisms
studied. Bacterial adherence can be mediated by specific proteins present in the
surface of bacteria, which recognize specific receptors on the surface of epithelial
cells. (Bavington et al. 2005; Klemm et al. 2010; Sharon 2006) The specificity of
these lectin-like adhesins depends greatly on the bacterial species and may vary
greatly among organisms, even among bacterial strains. For this reason, not all
the proposed oligosaccharides or plant extracts will necessarily inhibit pathogen
adherence to the surface of epithelial cells.
Mannan oligosaccharides (MOS) from yeast cell walls have been shown
to be important in the reduction of pathogen colonization (K. Newman et al.
1994). Many gram-negative bacteria attach to the surface of epithelial cells via
mannose-specific fimbriae (Ofek et al. 1977); MOS can act as a molecular decoy
to inhibit adherence of these pathogens to epithelial cells. Spring et al. 2000
reported that multiple strains of Salmonella and Escherichia coli agglutinated
MOS in vitro. In this study, mannan obtained from the cell wall of yeast showed
inhibition of different bacterial strains to epithelial cells.
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Conclusions
Collectively, our results showed that different oligosaccharides and plant
extracts reduce adherence of Escherichia coli and Salmonella typhimurium in
tissue culture cells. However, not all of the oligosaccharides tested were
effective in reducing adherence, suggesting that binding inhibition depends on
the adherence mechanism of the organism and the specific structure of the
oligosaccharide. Further research is needed to determine whether the
compounds tested can be food grade and if the concentration at which they
inhibit is within the economic and functional ranges suitable for food products.
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Figure 1. Adherence of EPEC, EHEC, and Salmonella typhimurium to HEp-2
cells in the presence of a cranberry HMW component (0, 0.2, 0.4, 0.8, 1, and 2
mg/ml) analyzed by qRT-PCR (n=6) (A, C) and microscopic counting (n=4) (B, D,
F). Statistically significant effects are indicated by an asterisk.
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Figure 2. Adherence of EPEC and Salmonella typhimurium to HEp-2 cells in the
presence of a neutralized cranberry concentrate analyzed by qRT-PCR (n=6).
Statistically significant effects are indicated by an asterisk.
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Figure 3. Adherence of EPEC to HEp-2 cells in the presence of COS analyzed
by microscopic enumeration. (n=6) Statistically significant effects are indicated by
an asterisk.
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Figure 4. Adherence of EPEC, EHEC, and Salmonella typhimurium to HEp-2
cells in the presence of MOSk analyzed by qRT-PCR (n=6) (A, C, D) and
microscopic counting (n=4) (B). Statistically significant effects are indicated by an
asterisk.

D

MOSk (mg/ml)

10
0

75

6.5

*

10
0

6.0

*

75

*
*

50

7.0

50

25

10

0

log CFU/ml Salmonella Typhimurium

*

25

10

0

log CFU/ml EHEC

A
MOSk

7.5

MOSk (mg/ml)

C
MOSk

7.0

6.5

6.0

5.5

5.0

4.2

4.0

MOSk (mg/ml)

MOSk (mg/ml)

B
10
0

4.4

75

4.6

50

MOSk

25

4.8

EPEC / 100 HEp-2 cells

5.0

10

0

10
0

75

50

25

10

0

log CFU/ml EPEC

109

MOSk

150

100

50

0

110

Figure 5. Adherence of EPEC, EHEC, and Salmonella typhimurium to HEp-2
cells in the presence of MOSy by qRT-PCR (A, C, D) (n=6) and microscopic
counting (B) (n=4). Statistically significant effects are indicated by an asterisk.
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Chapter 4
Lactoferrin as an anti-adherent agent: Inhibition of Cronobacter sakazakii
adherence to epithelial cells
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Abstract
Cronobacter sakazakii is now recognized as an opportunistic pathogen and has
been implicated in rare but severe cases of NEC, meningitis, and sepsis in
neonates. The first step in bacterial pathogenesis requires the organism to
adhere to host cells surfaces; therefore, agents that inhibit adhesion might be
useful for preventing infections. Lactoferrin, an iron binding protein found in milk,
has been shown to inhibit bacterial adherence by direct interaction and disruption
of bacterial surfaces. Therefore, the goal of this research was to assess the
ability of two different types of lactoferrin to inhibit adherence of Cronobacter
sakazakii to a HEp-2 human cell line. Results showed that the adherence of C.
sakazakii was significantly reduced at a minimum concentration of 10 mg/ml.
However, at higher concentrations (up to 50 mg/ml), further reductions in
adherence were not observed. These results suggest that lactoferrin might
interact with C. sakazakii and directly inhibit adhesion to tissue culture cells.
Introduction
Lactoferrin (Lf) is an 80 kDa iron binding glycoprotein, belonging to the
transferrin family. It is found in high concentrations, up to to 7 g/L in human
colostrum (Actor et al. 2009) and up to 1.5 mg/ml in bovine colostrum (Yekta et
al. 2010). It is also present in fluids of the digestive tract (Giugliano et al. 1995;
Legrand et al. 2005). The concentration of lactoferrin in milk varies over time and
is dependent on the stage of lactation (Farnaud 2003).
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Several biological functions have been attributed to lactoferrin. It has
bactericidal and bacteriostatic properties, as well as anti-inflammatory and
immunomodulatory activities, based on both in-vitro and in-vivo models (Gomez
et al. 2003). In particular, lactoferrin is known for its antimicrobial activity, for
which at least two different mechanisms have been proposed. The first model is
based on the ability of LF to bind iron, hence depriving pathogens from essential
nutrients and thereby inhibiting their growth (Farnaud 2003; Jenssen et al. 2009).
This antimicrobial activity is reduced upon iron saturation of the molecule,
suggesting that LF is bacteriostatic rather than bactericidal (Farnaud 2003;
Arnold et al. 1980; Kalmar et al. 1988; Yamauchi et al. 1993; Valenti et al. 2005).
A second means by which LF exhibits antimicrobial activity is via an ironindependent mechanism. According to this model, LF inhibits bacterial
pathogens by a direct interaction mediated by binding of the Lipid A portion of the
lipopolysaccharide (LPS) of Gram negative bacteria (Appelmelk et al. 1994;
Brandenburg et al. 2001; Shahriar et al. 2006). This then leads to the disruption
of the bacterial membrane and results in the release of LPS (Ellison et al. 1988;
Appelmelk et al. 1994; Brandenburg et al. 2001).
There is now evidence that lactoferrin can also inhibit bacterial adherence
to host cell surfaces, which is the first step for bacterial pathogenesis. It is well
known that many enteric pathogens, including enteropathogenic E. coli (EPEC),
adhere to and infect host cells via a Type III secretion system. By blocking the
initial step of EPEC attachment to host cells, the actin polymerization step of the
TTSS cascade is impaired (Ochoa et al. 2003). Other investigations (Qiu 1998)
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demonstrated that human lactoferrin also has proteolytic activity, hence providing
an additional mechanism by which it can exhibit anti-adherent activity (Valenti et
al. 2005). In addition, it was also reported (Yekta et al. 2010) that lactoferrin
inhibits adherence of E. coli O157:H7 to Caco-2 cells in a dose dependant
manner, mainly due to disruption of the Type III Secretory System.
In addition to its anti-adherence role, Lactoferrin has been identified as a critical
component for mediating immune responses. It reduces oxidative stress, thus
controlling excess inflammatory response (Actor et al. 2009). It may limit the
inflammation caused by bacterial infections, which can lead to prevention of
septic shock (Legrand et al. 2008). Along with its anti-inflammatory properties, it
is involved in many events related to immune responses, such as modulation for
cytokine production, chemokine recognition and lymphocyte migration (Actor et
al. 2009).
Cronobacter sakazakii is now considered an opportunistic pathogen that
has been implicated in bacteremia, necrotizing enterocolitis (NEC), and neonatal
meningitis (Healy et al. 2010). Although C. sakazakii infections are more
common in neonates and premature babies, it has been reported that immune
compromised adults are also susceptible to infections caused by this bacterium
(Healy et al. 2010). The infant mortality rate associated with C. sakazakii
infections ranges from 40 to 80% (Bowen et al. 2006). In addition, survivors often
develop serious long-term neurological complications (Lai 2001). Despite the
relatively low incidence of disease, the severity of these diseases has led to
considerable interest in developing strategies for preventing or mitigating
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infections. Therefore, the main goal of this research was to assess the ability of
lactoferrin to inhibit adherence of C. sakazakii to a human cell line.
Materials and Methods
Organisms and growth conditions. Strains of C. sakazakii used in this study
were obtained from K. Venkitanarayanan (Department of Animal Science,
University of Connecticut) and conditions for their growth have been previously
described(Quintero et al. 2011). Briefly, frozen stock cultures of each organism
were thawed, plated onto Tryptic Soy Agar (TSA; Difco) and grown overnight at
37°C. A single colony was inoculated into 10 ml of Tryptic Soy Broth (TSB;
Difco) and incubated aerobically, without shaking. Preliminary experiments
revealed that adherence rates were highest when cells were in late log phase.
Therefore, a 1% inoculum was incubated for 4 hours at 37°C without shaking.
Cultures were harvested by centrifugation (3,184 x g for 8 minutes), washed
once with phosphate-buffered saline (PBS) and re-suspended in minimal
essential medium (MEM; Hyclone, Logan, Utah), supplemented with 10% fetal
bovine serum (FBS; Hyclone). Minimal essential medium was pre-equilibrated at
tissue culture conditions (5% CO2, 95% relative humidity, 37°C). Based on
additional preliminary experiments, strain 4603 repeatedly gave the high
adherence rates on HEp-2 cells and was used for all subsequent experiments.
Lactoferrin. Two different types of lactoferrin (003 and 004) were obtained from
Mead Johnson Nutrition (Evansville, IN). The lactoferrin was prepared as
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concentrated stock solutions with distilled sterile water at a final concentration of
100 mg/ml. The solutions were filter sterilized using 0.22 µm filters.
Tissue culture cells. HEp-2 cells were obtained from the American Type
Culture Collection (ATCC; Manassas, Virginia). Cells were grown in 75 cm2
tissue culture flasks (Corning) containing 25 ml of MEM supplemented with 10%
FBS in a CO2 incubator at tissue culture conditions. Confluent Hep-2 cells were
harvested by adding 0.5 ml of 0.25% Trypsin-EDTA Solution (Sigma) and
incubating for 15 minutes at tissue culture conditions. Trypsin was inactivated
with 0.5 ml of FBS. Cells were then seeded onto 12-mm diameter glass
coverslips in 24-well tissue culture plates (Falcon) at approximately 3.6 x 105
viable cells per well, and 500 µl of MEM supplemented with 10% FBS was added
to each well. Plates were incubated under tissue culture conditions 30 hours
prior to the start of each experiment, or until confluency was reached.
Adherence Assays. Cell suspensions of C. sakazakii 4603 for HEp-2 cells were
prepared as described above. Lactoferrin was mixed with bacterial cultures (in
MEM supplemented with FBS) prior to addition to the tissue culture cells. The
plates were incubated for 30 minutes at tissue culture conditions. Preliminary
experiments indicated that 30 minutes of incubation were optimal for adherence
of the bacterial strains to the HEp-2 tissue culture.
Quantitative Real Time PCR (qRT-PCR). Bacterial cells from adherence
assays were detached by the addition of 1 ml of 0.1% Triton X-100 for 30
minutes at room temperature. Bacterial cells were harvested and centrifuged for
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5 min at 10,000 x g, supernatant was discarded and pellet was resuspended in
180 µl of buffer ATL from the DNeasy Blood and Tissue Kit (Qiagen, Hilden,
Germany). Instructions provided in the manufacturer’s manual for DNA
extraction of Gram negative bacteria were followed to complete the extraction.
Quantitative real time PCR (qRT-PCR) was performed using a Mastercycler
Realplex2 (Eppendorf AG, Hamburg, Germany). Each PCR was done in a 25 µl
volume. The reaction mixture comprised 11.25 µl of the 20x SYBR solution and
2.5-µl Real-MasterMix (5Prime), 0.5 µM of each primer, and 1µl of DNA template
(Martínez et al. 2009). Specific primers and amplification program were followed
for each organism. (Table 1)
Results
Lactoferrin 003 inhibits adherence of C. sakazakii to HEp-2 cells. Adherence
of C. sakazakii 4603 in the presence and absence of lactoferrin 003 was
measured by qRT-PCR. Initial doses ranged from 0.1 to 1.0 mg/ml. However, no
inhibition was observed at these concentrations (data not shown). Subsequently,
doses of 2 to 50 mg/ml were tested. Adherence inhibition was observed at a
minimum concentration of 10 mg/ml. Higher concentrations, however, did not
show a further antiadhesive effect (Figure 1).
Lactoferrin 004 inhibits adherence of C. sakazakii to HEp-2 cells. Adherence
of C. sakazakii 4603 in the presence and absence of lactoferrin 004 was
performed as for lactoferrin 003. As before, adherence inhibition was observed
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at a minimum concentration of 10 mg/ml and higher concentrations had no
additional effect (Figure 2).
Discussion
Among the biological functions attributed to lactoferrin are antimicrobial,
anti-inflammatory, and immunomodulatory activities (Kruzel et al. 2002; Legrand
et al. 2008; Actor et al. 2009; Brock 2002; Ward et al. 2002). The mechanisms
that account for the antimicrobial properties have been reported to be iron
dependent and independent (Bullen et al. 1972; Arnold et al. 1980; Orsi 2004;
Dalmastri et al. 1988; Bortner et al. 1989); the latter implying direct interaction of
lactoferrin with the bacterial cell surface (Appelmelk et al. 1994; Brandenburg et
al. 2001; Shahriar et al. 2006). This direct interaction can result in the inability of
the bacterium to adhere to host cell surfaces (Qiu 1998; Jenssen et al. 2009;
Ochoa et al. 2003; DeVinney et al. 1999; Goosney et al. 1999). Previous studies
have shown that lactoferrin prevents colonization of Haemophilus influenzae,
degrades virulence proteins secreted by Shigella flexeneri, and inhibits
adherence of Salmonella typhimurium, as well as it interferes with the Type III
Secretory System present in many pathogenic bacteria (Qiu 1998; Jenssen et al.
2009; Gomez et al. 2003; DeVinney et al. 1999; Goosney et al. 1999; Gomez et
al. 2001; Ochoa et al. 2003; Bessler et al. 2006).
Our results show that two different types of lactoferrin inhibit adherence of
Cronobacter sakazakii 4603. The mechanism by which C. sakazakii adheres to
host cell surfaces has not been well studied, although it has been established
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that an outer membrane protein A (OmpA) might play an important role in the
attachment and invasion of Caco-2 cells (Kim et al. 2008). The mechanism by
which lactoferrin inhibits adherence of C. sakazakii to HEp-2 cells requires further
investigation to determine whether it is strictly dependent on direct interaction of
lactoferrin with the bacterial cell surface. Interestingly, lactoferrin inhibits C.
sakazakii 4603 at a minimum required concentration of 10 mg/ml, although
inhibition does not increase significantly by further increasing the lactoferrin dose.
This suggests that lactoferrin may directly interact with the bacterial surface of
Cronobacter sakazakii, as a mechanism to inhibit its adherence to epithelial cells.
Therefore, upon saturation, there will not be a greater antiadherent effect with
higher lactoferrin concentrations.
Conclusion
Altogether, our results show that lactoferrin 003 and lactoferrin 004 inhibit
adherence of Cronobacter sakazakii 4603 to HEp-2 cells. Although the minimum
concentration to inhibit adherence was found to be 10 mg/ml, further research is
needed to establish the means by which lactoferrin interacts with C. sakazakii to
inhibit its adherence.
The first, and a crucial step in bacterial pathogenesis, is bacterial adhesion to
host cell surfaces. Agents that inhibit pathogen adherence, such as lactoferrin,
may be considered as food ingredients that might serve as a prophylactic
treatment to prevent infections.
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Figure 1. Adherence of Cronobacter sakazakii 4603 to HEp-2 cells in the
presence of Lactoferrin 003 at doses ranging from 0 to 50 mg/ml. Statistically
significant effects are indicated by an asterisk.
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Figure 2. Adherence of Cronobacter sakazakii 4603 to HEp-2 cells in the
presence of Lactoferrin 004 at doses ranging from 0 to 50 mg/ml. Statistically
significant effects are indicated by an asterisk.
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Table 1. Primers and qRT-PCR program
Table 1.
Organism

Primers (5’ - 3’)

Amplification Program

C. sakazakii

For TATAGGTTGTCTGCGAAAGCG

denaturation at 95°C for 10 s, 45

Rev GTCTTCGTGTGCGAGTTTG

cycles consisted of denaturation at
95°C for 5 s, 62°C for 20 s for
annealing and extension.
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Chapter 5
Conclusion
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In this research we established that several food-grade prebiotic carbohydrates,
plant extracts, and other naturally-derived molecules inhibit adherence of enteric
pathogens to epithelial cells. Specifically, GOS and PDX, alone and in
combination, as well as lactoferrin inhibit adherence of Cronobacter sakazakii to
a HEp-2 cell line. Furthermore, it was determined that a high molecular weight
component from cranberry, mannan from yeast, and chitin oligosaccharides,
inhibit adherence of EPEC, EHEC, and Salmonella typhimurium to epithelial
cells. The major findings of this research are described below.
•

GOS and a blend of GOS-PDX effectively reduce adherence of C.
sakazakii in tissue culture experiments.

•

There is enough similarity between GOS and human milk
oligosaccharides to be effective in inhibiting adherence at the
concentration used in this study.

•

The antiadherent effect of prebiotic oligosaccharides varies among
different strains and epithelial cell lines.

•

Different oligosaccharides and plant extracts inhibit adherence of EPEC,
EHEC, and Salmonella typhimurium to tissue culture cells.

•

The high molecular weight component of cranberry inhibits adherence of
the three enteric pathogens used in this study, at concentrations ranging
from 0.2 to 2 mg/ml.

•

Mannan from yeast cells inhibits adherence of EPEC and Salmonella
typhimurium at a minimum concentration of 75 and 10 mg/ml, respectively.
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•

Mannan from konjac root does not inhibit adherence of any of the tested
enteric pathogens.

•

Different fractions of chitin oligosaccharides reduce adherence of EPEC to
a HEp-2 cell line. Reduction in adherence is mainly due to adherence
inhibition rather than by a bactericidal effect.

•

Lactoferrin inhibits adherence of Cronobacter sakazakii to a human
epithelial cell line,

•

The minimum lactoferrin concentration required for C. sakazakii
adherence inhibition is 10 mg/ml; higher concentrations do not exhibit
higher adherence inhibition.

•

Collectively, these results provide a basis for development of natural
prophylactic agents that may be effective at reducing or preventing
infections by enteric pathogens.

•

In addition, the results of this research suggests that food-grade antiadherent agents may serve as a substitute for the widespread use of
antibiotics whose use in animal agriculture may soon be restricted.

